Gene expression analysis of pretreatment biopsies predicts the pathological response of esophageal squamous cell carcinomas to neo-chemoradiotherapy

Annals of Oncology

Volumn 25, Issue 9, 2014, Pages 1769-1774

  Wen, J ^a,b   Yang, H ^a,b   Liu, M Z ^a,b   Luo, K J ^a,b   Liu, H ^a,b   Hu, Y ^a,b   Zhang, X ^a,b   Lai, R C ^a   Lin, T ^a,b   Wang, H Y ^a,b   Fu, J H ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b Guangdong Esophageal Cancer Research Institute   (China)

Author keywords

Esophageal squamous cell carcinoma; Gene expression; Neoadjuvant chemoradiotherapy; Response prediction

Indexed keywords

BIOLOGICAL MARKER; CISPLATIN; MESSENGER RNA; NAVELBINE; ANTINEOPLASTIC AGENT; VINBLASTINE; INTERSTITIAL COLLAGENASE;

ACCURACY; ADJUVANT CHEMORADIOTHERAPY; ADULT; AREA UNDER THE CURVE; ARTICLE; C1ORF226 GENE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GSTM3 GENE; HUMAN; IGSF10 GENE; LIMCH1 GENE; MALE; MICROARRAY ANALYSIS; MMP1 GENE; MMP12 GENE; MMP9 GENE; OASL GENE; ONCOGENE; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCORING SYSTEM; SDPR GENE; SENSITIVITY AND SPECIFICITY; SLC9A9 GENE; TREATMENT RESPONSE; TUMOR BIOPSY; TUMOR LOCALIZATION; VALIDITY; ADJUVANT THERAPY; ANALOGS AND DERIVATIVES; BIOPSY; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CLINICAL TRIAL; ESOPHAGEAL NEOPLASMS; GENETICS; MIDDLE AGED; MORTALITY; PHASE 3 CLINICAL TRIAL; TREATMENT OUTCOME; COHORT ANALYSIS; ESOPHAGUS BIOPSY; ESOPHAGUS SURGERY; GENE; HISTOPATHOLOGY; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PATHOLOGICAL COMPLETE RESPONSE; PHASE 3 CLINICAL TRIAL (TOPIC); PREDICTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; RNA, MESSENGER; TREATMENT OUTCOME; VINBLASTINE;

EID: 84906856209     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdu201     Document Type: Article

References (15)

1. Jemal A, Bray F, Center MM et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Herskovic A, Russell W, Liptay M et al. Esophageal carcinoma advances in treatment results for locally advanced disease: review. Ann Oncol 2012; 23: 1095-1103.
3. Allum WH, Blazeby JM, Griffin SM et al. Guidelines for the management of oesophageal and gastric cancer. Gut 2011; 60: 1449-1472.
4. Berger AC, Farma J, Scott WJ et al. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 2005; 23: 4330-4337.
5. Rohatgi P, Swisher SG, Correa AM et al. Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response. Cancer 2005; 104: 2365-2372.
6. Yang H, Fu JH, Liu MZ et al. A multi-centered randomized controlled study of neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of esophagus: an interim analysis. Zhonghua Yi Xue Za Zhi 2012; 92: 1028-1032.
7. Luthra R, Wu TT, Luthra MG et al. Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation. J Clin Oncol 2006; 24: 259-267.
8. Duong C, Greenawalt DM, Kowalczyk A et al. Pretreatment gene expression profiles can be used to predict response to neoadjuvant chemoradiotherapy in esophageal cancer. Ann Surg Oncol 2007; 14: 3602-3609.
9. Maher SG, Gillham CM, Duggan SP et al. Gene expression analysis of diagnostic biopsies predicts pathological response to neoadjuvant chemoradiotherapy of esophageal cancer. Ann Surg 2009; 250: 729-737.
10. Schauer M, Janssen KP, Rimkus C et al. Microarray-based response prediction in esophageal adenocarcinoma. Clin Cancer Res 2010; 16: 330-337.
11. Motoori M, Takemasa I, Yamasaki M et al. Prediction of the response to chemotherapy in advanced esophageal cancer by gene expression profiling of biopsy samples. Int J Oncol 2010; 37: 1113-1120.
12. Nakasone ES, Askautrud HA, Kees T et al. Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. Cancer Cell 2012; 21: 488-503.
13. Cizkova M, Cizeron-Clairac G, Vacher S et al. Gene expression profiling reveals new aspects of PIK3CA mutation in ERalpha-positive breast cancer: major implication of the Wnt signaling pathway. PLoS One 2010; 5: e15647.
14. Eckel-Passow JE, Serie DJ, Bot BM et al. ANKS1B is a smoking-related molecular alteration in clear cell renal cell carcinoma. BMC Urol 2014; 14: 14.
15. Cronin M, Pho M, Dutta D et al. Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay. Am J Pathol 2004; 164: 35-42.